Highlights

[PHARMA] QoQ Quarter Result on 2013-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 15-May-2013
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2013
Quarter 31-Mar-2013  [#1]
Profit Trend QoQ -     412.21%    YoY -     -13.64%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 567,860 440,807 437,633 500,339 482,404 426,460 456,737 15.58%
  QoQ % 28.82% 0.73% -12.53% 3.72% 13.12% -6.63% -
  Horiz. % 124.33% 96.51% 95.82% 109.55% 105.62% 93.37% 100.00%
PBT 33,007 13,461 9,605 36,924 4,248 28,493 27,618 12.58%
  QoQ % 145.20% 40.15% -73.99% 769.21% -85.09% 3.17% -
  Horiz. % 119.51% 48.74% 34.78% 133.70% 15.38% 103.17% 100.00%
Tax -11,740 -9,291 -3,434 -11,771 -11,716 -2,957 -11,541 1.14%
  QoQ % -26.36% -170.56% 70.83% -0.47% -296.21% 74.38% -
  Horiz. % 101.72% 80.50% 29.75% 101.99% 101.52% 25.62% 100.00%
NP 21,267 4,170 6,171 25,153 -7,468 25,536 16,077 20.44%
  QoQ % 410.00% -32.43% -75.47% 436.81% -129.24% 58.84% -
  Horiz. % 132.28% 25.94% 38.38% 156.45% -46.45% 158.84% 100.00%
NP to SH 20,813 3,751 5,865 24,771 -7,934 25,247 15,713 20.55%
  QoQ % 454.87% -36.04% -76.32% 412.21% -131.43% 60.68% -
  Horiz. % 132.46% 23.87% 37.33% 157.65% -50.49% 160.68% 100.00%
Tax Rate 35.57 % 69.02 % 35.75 % 31.88 % 275.80 % 10.38 % 41.79 % -10.16%
  QoQ % -48.46% 93.06% 12.14% -88.44% 2,557.03% -75.16% -
  Horiz. % 85.12% 165.16% 85.55% 76.29% 659.97% 24.84% 100.00%
Total Cost 546,593 436,637 431,462 475,186 489,872 400,924 440,660 15.40%
  QoQ % 25.18% 1.20% -9.20% -3.00% 22.19% -9.02% -
  Horiz. % 124.04% 99.09% 97.91% 107.84% 111.17% 90.98% 100.00%
Net Worth 486,672 473,402 480,568 484,829 472,037 496,469 481,394 0.73%
  QoQ % 2.80% -1.49% -0.88% 2.71% -4.92% 3.13% -
  Horiz. % 101.10% 98.34% 99.83% 100.71% 98.06% 103.13% 100.00%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 16,049 7,760 8,810 8,825 11,771 11,764 8,827 48.80%
  QoQ % 106.81% -11.91% -0.17% -25.02% 0.06% 33.27% -
  Horiz. % 181.82% 87.91% 99.81% 99.98% 133.35% 133.27% 100.00%
Div Payout % 77.11 % 206.90 % 150.22 % 35.63 % - % 46.60 % 56.18 % 23.43%
  QoQ % -62.73% 37.73% 321.61% 0.00% 0.00% -17.05% -
  Horiz. % 137.26% 368.28% 267.39% 63.42% 0.00% 82.95% 100.00%
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 486,672 473,402 480,568 484,829 472,037 496,469 481,394 0.73%
  QoQ % 2.80% -1.49% -0.88% 2.71% -4.92% 3.13% -
  Horiz. % 101.10% 98.34% 99.83% 100.71% 98.06% 103.13% 100.00%
NOSH 258,868 258,689 258,370 117,676 117,715 117,646 117,700 68.88%
  QoQ % 0.07% 0.12% 119.56% -0.03% 0.06% -0.05% -
  Horiz. % 219.94% 219.79% 219.52% 99.98% 100.01% 99.95% 100.00%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 3.75 % 0.95 % 1.41 % 5.03 % -1.55 % 5.99 % 3.52 % 4.30%
  QoQ % 294.74% -32.62% -71.97% 424.52% -125.88% 70.17% -
  Horiz. % 106.53% 26.99% 40.06% 142.90% -44.03% 170.17% 100.00%
ROE 4.28 % 0.79 % 1.22 % 5.11 % -1.68 % 5.09 % 3.26 % 19.84%
  QoQ % 441.77% -35.25% -76.13% 404.17% -133.01% 56.13% -
  Horiz. % 131.29% 24.23% 37.42% 156.75% -51.53% 156.13% 100.00%
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 219.36 170.40 169.38 425.18 409.81 362.49 388.05 -31.56%
  QoQ % 28.73% 0.60% -60.16% 3.75% 13.05% -6.59% -
  Horiz. % 56.53% 43.91% 43.65% 109.57% 105.61% 93.41% 100.00%
EPS 8.04 1.45 2.27 21.05 -6.74 21.46 13.35 -28.62%
  QoQ % 454.48% -36.12% -89.22% 412.31% -131.41% 60.75% -
  Horiz. % 60.22% 10.86% 17.00% 157.68% -50.49% 160.75% 100.00%
DPS 6.20 3.00 3.41 7.50 10.00 10.00 7.50 -11.89%
  QoQ % 106.67% -12.02% -54.53% -25.00% 0.00% 33.33% -
  Horiz. % 82.67% 40.00% 45.47% 100.00% 133.33% 133.33% 100.00%
NAPS 1.8800 1.8300 1.8600 4.1200 4.0100 4.2200 4.0900 -40.36%
  QoQ % 2.73% -1.61% -54.85% 2.74% -4.98% 3.18% -
  Horiz. % 45.97% 44.74% 45.48% 100.73% 98.04% 103.18% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 217.38 168.74 167.53 191.53 184.67 163.25 174.84 15.58%
  QoQ % 28.83% 0.72% -12.53% 3.71% 13.12% -6.63% -
  Horiz. % 124.33% 96.51% 95.82% 109.55% 105.62% 93.37% 100.00%
EPS 7.97 1.44 2.25 9.48 -3.04 9.66 6.01 20.64%
  QoQ % 453.47% -36.00% -76.27% 411.84% -131.47% 60.73% -
  Horiz. % 132.61% 23.96% 37.44% 157.74% -50.58% 160.73% 100.00%
DPS 6.14 2.97 3.37 3.38 4.51 4.50 3.38 48.72%
  QoQ % 106.73% -11.87% -0.30% -25.06% 0.22% 33.14% -
  Horiz. % 181.66% 87.87% 99.70% 100.00% 133.43% 133.14% 100.00%
NAPS 1.8630 1.8122 1.8396 1.8559 1.8070 1.9005 1.8428 0.73%
  QoQ % 2.80% -1.49% -0.88% 2.71% -4.92% 3.13% -
  Horiz. % 101.10% 98.34% 99.83% 100.71% 98.06% 103.13% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 4.4500 4.8200 4.4900 8.2600 8.1000 7.5500 10.1800 -
P/RPS 2.03 2.83 2.65 1.94 1.98 2.08 2.62 -15.60%
  QoQ % -28.27% 6.79% 36.60% -2.02% -4.81% -20.61% -
  Horiz. % 77.48% 108.02% 101.15% 74.05% 75.57% 79.39% 100.00%
P/EPS 55.35 332.41 197.80 39.24 -120.18 35.18 76.25 -19.18%
  QoQ % -83.35% 68.05% 404.08% 132.65% -441.61% -53.86% -
  Horiz. % 72.59% 435.95% 259.41% 51.46% -157.61% 46.14% 100.00%
EY 1.81 0.30 0.51 2.55 -0.83 2.84 1.31 23.98%
  QoQ % 503.33% -41.18% -80.00% 407.23% -129.23% 116.79% -
  Horiz. % 138.17% 22.90% 38.93% 194.66% -63.36% 216.79% 100.00%
DY 1.39 0.62 0.76 0.91 1.23 1.32 0.74 52.06%
  QoQ % 124.19% -18.42% -16.48% -26.02% -6.82% 78.38% -
  Horiz. % 187.84% 83.78% 102.70% 122.97% 166.22% 178.38% 100.00%
P/NAPS 2.37 2.63 2.41 2.00 2.02 1.79 2.49 -3.23%
  QoQ % -9.89% 9.13% 20.50% -0.99% 12.85% -28.11% -
  Horiz. % 95.18% 105.62% 96.79% 80.32% 81.12% 71.89% 100.00%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 -
Price 4.2900 4.7200 4.6600 9.2600 7.8000 8.2500 8.8300 -
P/RPS 1.96 2.77 2.75 2.18 1.90 2.28 2.28 -9.57%
  QoQ % -29.24% 0.73% 26.15% 14.74% -16.67% 0.00% -
  Horiz. % 85.96% 121.49% 120.61% 95.61% 83.33% 100.00% 100.00%
P/EPS 53.36 325.52 205.29 43.99 -115.73 38.44 66.14 -13.30%
  QoQ % -83.61% 58.57% 366.67% 138.01% -401.07% -41.88% -
  Horiz. % 80.68% 492.17% 310.39% 66.51% -174.98% 58.12% 100.00%
EY 1.87 0.31 0.49 2.27 -0.86 2.60 1.51 15.28%
  QoQ % 503.23% -36.73% -78.41% 363.95% -133.08% 72.19% -
  Horiz. % 123.84% 20.53% 32.45% 150.33% -56.95% 172.19% 100.00%
DY 1.45 0.64 0.73 0.81 1.28 1.21 0.85 42.63%
  QoQ % 126.56% -12.33% -9.88% -36.72% 5.79% 42.35% -
  Horiz. % 170.59% 75.29% 85.88% 95.29% 150.59% 142.35% 100.00%
P/NAPS 2.28 2.58 2.51 2.25 1.95 1.95 2.16 3.66%
  QoQ % -11.63% 2.79% 11.56% 15.38% 0.00% -9.72% -
  Horiz. % 105.56% 119.44% 116.20% 104.17% 90.28% 90.28% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

233  595  579  1044 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.18-0.22 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.965-0.035 
 DGSB 0.22+0.005 
 VC 0.05-0.005 
 DATAPRP 0.195-0.025 
 KSTAR 0.41+0.04 
 MTOUCHE 0.05-0.005 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS